+
Site Tour
TRICLIP™
TRICUSPID
VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

 

Built upon a proven clip-based platform, TriClip™ Transcatheter Edge-to-Edge Repair (TEER) offers a minimally invasive treatment option for patients with symptomatic, severe Tricuspid Regurgitation (TR) who are at high risk for surgery.

THE TRICUSPID VALVE HAS FINALLY
MET ITS MATCH

TRICLIP™ G4 TEER SYSTEM.
UNMATCHED STABILITY, PRECISION, CONTROL.2

The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery for complex conditions.

* Based on Abbott simulated horizontal tensile testing.

TRICLIP™ eLABELLING SITE

F/E Knob

S/L Knob

Steerable Guide Catheter

+/- Knob

Distal Curve

TriclipTM G4 Delivery System

Controlled Gripper Actuation

Actuator Knob

  • Flexes and extends delivery catheter to steer down to the valve plane

  • Enables movement in septal or lateral direction

  • Designed for the tricuspid anatomy
    • Provides adequate height over the valve
    • Maintains coaxial position during steering and positioning
    • Allows sweeping away from the septum to optimize delivery catheter while maintaining perpendicularity to the plane of the valve

  • Straightens or curves the guide to add or subtract height above the valve

  • Designed for direct access to the tricuspid valve

    • Provides stability and precision during steering and positioning
    • Multiaxis steering to enable navigation across all lines of coaptation

  • Confirm and optimize leaflet grasping

  • Simultaneous implant and gripper detachment

EPIC™ SUPRA AORTIC STENTED TISSUE VALVE FEATURES
1
2
3
4
5
6
7
8
    • Provides stability and precision during steering and positioning
    • Multiaxis steering to enable navigation across all lines of coaptation
  2. Flexes and extends delivery catheter to steer down to the valve plane
  3. Enables movement in septal or lateral direction
  4. Straightens and curves guide for height adjustment above the valve

  5. Designed for the tricuspid anatomy

    • Provides adequate height over the valve
    • Maintains coaxial position during steering and positioning
    • Allows sweeping away from the septum to optimize delivery catheter while maintaining perpendicularity to the plane of the valve
  6. Designed for direct access to the tricuspid valve
  7. Confirm and optimize leaflet grasping
  8. Simultaneous implant and gripper detachment
Building on a legacy of unmatched TEER expertise1

TriClip™ implants use the same proven leaflet technology as our MitraClip™ Transcatheter Edge-to-Edge Repair (TEER). TriClip™ TEER is the clip-based technology physicians know and trust, with a delivery system uniquely designed for the tricuspid valve.

TriClip™ Implant Features:

  • Cobalt-chromium and Nitinol construction
  • Polyester cover designed to promote tissue growth
  • Magnetic resonance conditional to 3 Tesla†

†Static magnetic field up to 3 T; maximum spatial gradient in static field of 4000 gauss/cm or less; maximum whole-body averaged specific absorption rate (SAR) of 2 W/kg for 15 minutes of scanning

More options to confirm and optimize leaflet grasping with Controlled Gripper Actuation (CGA)1,**
Optimized leaflet capture

OPTIMIZED LEAFLET CAPTURE FOR CONSISTENT TR REDUCTION WITH THE TRICLIP™ G4 TEER SYSTEM

  • Wide grasp opening allows full leaflet insertion1
  • Designed to distribute retention forces across the leaflets1
  • Controlled gripper actuation enables independent leaflet grasping and confirmation, when needed1

 

Connext
Live

Hear from the most respected KOLs in cardiovascular and stroke prevention, collaborate on best practice and be part of the CONNEXT community.

Find out more

 

 

TV

AV VALVES 2023: Fast Forward 20 Years

AV VALVES Summit 2023 Shaping the Future Part II: Fast Forward 20 Years

AV VALVES 2023: The Genesis of TEER

AV VALVES Summit 2023 Shaping the Future Part I: 20 years – The Genesis of TEER

AV VALVES 2023: TA, TF in TMVR

AV VALVES Summit 2023 Trending Controversies Round 3: TA, TF in TMVR

AV VALVES 2023: Replace, Repair in TR

AV VALVES Summit 2023 Trending Controversies Round 2: Replace, Repair in TR

AV VALVES 2023: Staged, Concomitant

AV VALVES Summit 2023 Trending Controversies Round 1: Staged, Concomitant 

AV VALVES 2023:Decision Making in HF–Tricuspid

AV VALVES Summit 2023 Decision Making in HF:How & when should I treat? Part II Tricuspid

AV VALVES 2023:Decision Making in HF – Mitral

AV VALVES Summit 2023 Decision Making in HF: How & when should I treat? Part I Mitral 

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES Summit 2023 HF and VHD: Changing the Paradigm of Patient Management

AV VALVES 2023: Live Case – T-TEER

AV VALVES Summit 2023 Live Case: Tricuspid TEER

AV VALVES 2023: TR – Big Gaps

AV VALVES Summit 2023 Case Parade Tricuspid: Big Gaps

References
  1. Data on file at Abbott.
  2. Testing performed by and data on file at Abbott.
  3. von Bardeleben RS, Lurz P, Sitges M, et al. Percutaneous edge-to-edge repair for tricuspid regurgitation: 2-year outcomes from the TRILUMINATE trial. Presented at EuroPCR 2021.
  4. Lurz P, Schueler R, Goebel B, et al. Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip™ bRIGHT Study. Presented at PCR London Valves 2021.
  5. Lurz P, von Bardeleben RS, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol. 2021;77(3):229–239. doi.org/10.101 /j.jacc.2020.11.038.
  6. Benfari G, Antoine C, Mille WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196–206. doi.org/10.1161/CIRCULATIONAHA.118.038946.
  7. Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–2956. doi.org/10.1016/j.jacc.2018.04.031.
  8. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62(6):447–451. doi.org/10.1016/j.pcad.2019.10.009.
  9. Wong WK, Chen SW, Chou AH, et al. Late outcomes of valve repair versus replacement in isolated and concomitant tricuspid valve surgery: a nationwide cohort study. J Am Heart Assoc. 2020;9(8):e015637. doi.org/10.1161/JAHA.119.015637.
  10. Moraca RJ, Moon MR, Lawton JS, et al. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg. 2009;87(1):83–8; discussion 88¬–9. doi.org/10.1016/j.athoracsur.2008.10.003.

© Abbott 2023. All rights reserved. 9-EH-5-14379-01 07-2023

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline